Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 213-220

  Liu, Peng Fei ^a   Wu, Yun Yun ^a   Hu, You ^a   Wang, Lei ^a   He, Song Bing ^a,b   Zhu, Yi Bei ^a   Zhu, Xin Guo ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; Pancreatic adenocarcinoma upregulated factor; RNA interference; Wnt catenin

Indexed keywords

BETA CATENIN; PROTEIN PAUF; RNA; SECRETORY PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HCT116; COLORECTAL CANCER; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; BETA CATENIN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LECTINS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, SMALL INTERFERING; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84878208947     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2478     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. He SB, Yuan Y, Wang L, Yu MJ, Zhu YB and Zhu XG: Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells. J Exp Clin Cancer Res 30: 109, 2011.
3. Wan D, He S, Xie B, Xu G, Gu W, Shen C, Hu Y, Wang X, Zhi Q and Wang L: Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers. Med Oncol 30: 378, 2013.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
5. Markowitz SD and Bertagnolli MM: Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460, 2009.
6. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I and Kerr D: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499, 2009.
7. Chen HJ, Hsu LS, Shia YT, Lin MW and Lin CM: The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway. Biochem Pharmacol 84: 1143-1153, 2012.
8. Firestein R and Hahn WC: Revving the Throttle on an oncogene: CDK8 takes the driver seat. Cancer Res 69: 7899-7901, 2009.
9. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W and He TC: Wnt/β-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 4: 653-671, 2004. (Pubitemid 40013572)
10. Dihlmann S and von Knebel Doeberitz M: Wnt/β-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer 113: 515-524, 2005. (Pubitemid 40038726)
11. Kundu JK, Choi KY and Surh YJ: β-catenin-mediated signaling: a novel molecular target for chemoprevention with anti-inflammatory substances. Biochim Biophys Acta 1765: 14-24, 2006.
12. Kim SA, Lee Y, Jung DE, Park KH, Park JY, Gang J, Jeon SB, Park EC, Kim YG, Lee B, Liu Q, Zeng W, Yeramilli S, Lee S, Koh SS and Song SY: Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma. Cancer Sci 100: 828-836, 2009.
13. Cho IR, Koh SS, Min HJ, Kim SJ, Lee Y, Park EH, Ratakorn S, Jhun BH, Oh S, Johnston RN and Chung YH: Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells. Exp Mol Med 43: 82-90, 2011.
14. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
15. Nelson WJ and Nusse R: Convergence of Wnt, β-catenin, and cadherin pathways. Science 303: 1483-1487, 2004. (Pubitemid 38314410)
16. Coluccia AM, Benati D, Dekhil H, De Filippo A, Lan C and Gambacorti-Passerini C: SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling. Cancer Res 66: 2279-2286, 2006.
17. Seo JO, Han SI and Lim SC: Role of CDK8 and β-catenin in colorectal adenocarcinoma. Oncol Rep 24: 285-291, 2010.
18. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M and Hahn WC: CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature 455: 547-551, 2008.
19. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Näär AM and Dyson NJ: E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8. Nature 455: 552-556, 2008.
20. Lee Y, Kim SJ, Park HD, Park EH, Huang SM, Jeon SB, Kim JM, Lim DS and Koh SS: PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression. Oncogene 29: 56-67, 2010.
21. Park HD, Lee Y, Oh YK, Jung JG, Park YW, Myung K, Kim KH, Koh SS and Lim DS: Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. Oncogene 30: 201-211, 2011.
22. Lee YS, Kim SJ, Min HJ, Jo JY, Park EH and Koh SS: PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase. Exp Mol Med 43: 291-297, 2011.
23. Kim YH, Sung HJ, Kim S, Kim EO, Lee JW, Moon JY, Choi K, Jung JE, Lee Y, Koh SS, Rhee SG, Heo K, Kim IH: An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells. Cancer Lett 313: 76-83, 2011.
24. Merritt WM, Bar-Eli M and Sood AK: The dicey role of dicer: implications for RNAi therapy. Cancer Res 70: 2571-2574, 2010.
25. Brummelkamp TR, Bemards R and Agami R: Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247, 2002. (Pubitemid 41043979)